世界の感染症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Infectious Disease Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5800 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗菌剤、抗ウイルス剤、抗寄生虫剤、抗真菌剤、その他）、用途別市場規模（HIV、マラリア、肝炎、インフルエンザ、HPV、結核、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・感染症治療薬の市場動向 ・企業の競争状況、市場シェア ・感染症治療薬の種類別市場規模と予測2016-2027（抗菌剤、抗ウイルス剤、抗寄生虫剤、抗真菌剤、その他） ・感染症治療薬の用途別市場規模と予測2016-2027（HIV、マラリア、肝炎、インフルエンザ、HPV、結核、その他） ・感染症治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・感染症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・感染症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・感染症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・感染症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Gilead Sciences、Merck & Co.、Pfizer、Sanofi、AbbVie、Shire、Grifols、Johnson & Johnson、Protein Sciences、AstraZeneca） ・結論

Infectious Disease Drugs are drugs that relieve symptoms, resolve symptoms, or block the route of transmission.
The epidemic of infectious diseases has risen, spending has increased to increase the penetration of treatments for these diseases, initiatives to increase treatment awareness and awareness of these diseases, and increased clinical trial research on new drug development. The infectious disease drug market expanded.

Market Analysis and Insights: Global Infectious Disease Drugs Market
The global Infectious Disease Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Disease Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Disease Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Disease Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Disease Drugs market.

Global Infectious Disease Drugs Scope and Market Size
Infectious Disease Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Antibacterials
Antiviral drugs
Antiparasitic drugs
Antifungal
Others

Segment by Application
HIV
Malaria
Hepatitis
Influenza
HPV
Tuberculosis
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
Gilead Sciences
Merck & Co.
Pfizer
Sanofi
AbbVie
Shire
Grifols
Johnson & Johnson
Protein Sciences
AstraZeneca

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibacterials
1.2.3 Antiviral drugs
1.2.4 Antiparasitic drugs
1.2.5 Antifungal
1.2.6 Others
1.3 Market by Application
1.3.1 Global Infectious Disease Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 HIV
1.3.3 Malaria
1.3.4 Hepatitis
1.3.5 Influenza
1.3.6 HPV
1.3.7 Tuberculosis
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Infectious Disease Drugs Market Perspective (2016-2027)
2.2 Infectious Disease Drugs Growth Trends by Regions
2.2.1 Infectious Disease Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Infectious Disease Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Infectious Disease Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Infectious Disease Drugs Industry Dynamic
2.3.1 Infectious Disease Drugs Market Trends
2.3.2 Infectious Disease Drugs Market Drivers
2.3.3 Infectious Disease Drugs Market Challenges
2.3.4 Infectious Disease Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Drugs Players by Revenue
3.1.1 Global Top Infectious Disease Drugs Players by Revenue (2016-2021)
3.1.2 Global Infectious Disease Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Drugs Revenue
3.4 Global Infectious Disease Drugs Market Concentration Ratio
3.4.1 Global Infectious Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Drugs Revenue in 2020
3.5 Infectious Disease Drugs Key Players Head office and Area Served
3.6 Key Players Infectious Disease Drugs Product Solution and Service
3.7 Date of Enter into Infectious Disease Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Disease Drugs Breakdown Data by Type
4.1 Global Infectious Disease Drugs Historic Market Size by Type (2016-2021)
4.2 Global Infectious Disease Drugs Forecasted Market Size by Type (2022-2027)

5 Infectious Disease Drugs Breakdown Data by Application
5.1 Global Infectious Disease Drugs Historic Market Size by Application (2016-2021)
5.2 Global Infectious Disease Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Infectious Disease Drugs Market Size (2016-2027)
6.2 North America Infectious Disease Drugs Market Size by Type
6.2.1 North America Infectious Disease Drugs Market Size by Type (2016-2021)
6.2.2 North America Infectious Disease Drugs Market Size by Type (2022-2027)
6.2.3 North America Infectious Disease Drugs Market Size by Type (2016-2027)
6.3 North America Infectious Disease Drugs Market Size by Application
6.3.1 North America Infectious Disease Drugs Market Size by Application (2016-2021)
6.3.2 North America Infectious Disease Drugs Market Size by Application (2022-2027)
6.3.3 North America Infectious Disease Drugs Market Size by Application (2016-2027)
6.4 North America Infectious Disease Drugs Market Size by Country
6.4.1 North America Infectious Disease Drugs Market Size by Country (2016-2021)
6.4.2 North America Infectious Disease Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Infectious Disease Drugs Market Size (2016-2027)
7.2 Europe Infectious Disease Drugs Market Size by Type
7.2.1 Europe Infectious Disease Drugs Market Size by Type (2016-2021)
7.2.2 Europe Infectious Disease Drugs Market Size by Type (2022-2027)
7.2.3 Europe Infectious Disease Drugs Market Size by Type (2016-2027)
7.3 Europe Infectious Disease Drugs Market Size by Application
7.3.1 Europe Infectious Disease Drugs Market Size by Application (2016-2021)
7.3.2 Europe Infectious Disease Drugs Market Size by Application (2022-2027)
7.3.3 Europe Infectious Disease Drugs Market Size by Application (2016-2027)
7.4 Europe Infectious Disease Drugs Market Size by Country
7.4.1 Europe Infectious Disease Drugs Market Size by Country (2016-2021)
7.4.2 Europe Infectious Disease Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Drugs Market Size (2016-2027)
8.2 Asia-Pacific Infectious Disease Drugs Market Size by Type
8.2.1 Asia-Pacific Infectious Disease Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Infectious Disease Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Infectious Disease Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Infectious Disease Drugs Market Size by Application
8.3.1 Asia-Pacific Infectious Disease Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Infectious Disease Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Infectious Disease Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Infectious Disease Drugs Market Size by Region
8.4.1 Asia-Pacific Infectious Disease Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Infectious Disease Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Infectious Disease Drugs Market Size (2016-2027)
9.2 Latin America Infectious Disease Drugs Market Size by Type
9.2.1 Latin America Infectious Disease Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Infectious Disease Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Infectious Disease Drugs Market Size by Type (2016-2027)
9.3 Latin America Infectious Disease Drugs Market Size by Application
9.3.1 Latin America Infectious Disease Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Infectious Disease Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Infectious Disease Drugs Market Size by Application (2016-2027)
9.4 Latin America Infectious Disease Drugs Market Size by Country
9.4.1 Latin America Infectious Disease Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Infectious Disease Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Drugs Market Size (2016-2027)
10.2 Middle East & Africa Infectious Disease Drugs Market Size by Type
10.2.1 Middle East & Africa Infectious Disease Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Infectious Disease Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Infectious Disease Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Infectious Disease Drugs Market Size by Application
10.3.1 Middle East & Africa Infectious Disease Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Infectious Disease Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Infectious Disease Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Infectious Disease Drugs Market Size by Country
10.4.1 Middle East & Africa Infectious Disease Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Infectious Disease Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Infectious Disease Drugs Introduction
11.1.4 GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Infectious Disease Drugs Introduction
11.2.4 Gilead Sciences Revenue in Infectious Disease Drugs Business (2016-2021)
11.2.5 Gilead Sciences Recent Development
11.3 Merck & Co.
11.3.1 Merck & Co. Company Details
11.3.2 Merck & Co. Business Overview
11.3.3 Merck & Co. Infectious Disease Drugs Introduction
11.3.4 Merck & Co. Revenue in Infectious Disease Drugs Business (2016-2021)
11.3.5 Merck & Co. Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Infectious Disease Drugs Introduction
11.4.4 Pfizer Revenue in Infectious Disease Drugs Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Infectious Disease Drugs Introduction
11.5.4 Sanofi Revenue in Infectious Disease Drugs Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Infectious Disease Drugs Introduction
11.6.4 AbbVie Revenue in Infectious Disease Drugs Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 Shire
11.7.1 Shire Company Details
11.7.2 Shire Business Overview
11.7.3 Shire Infectious Disease Drugs Introduction
11.7.4 Shire Revenue in Infectious Disease Drugs Business (2016-2021)
11.7.5 Shire Recent Development
11.8 Grifols
11.8.1 Grifols Company Details
11.8.2 Grifols Business Overview
11.8.3 Grifols Infectious Disease Drugs Introduction
11.8.4 Grifols Revenue in Infectious Disease Drugs Business (2016-2021)
11.8.5 Grifols Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Infectious Disease Drugs Introduction
11.9.4 Johnson & Johnson Revenue in Infectious Disease Drugs Business (2016-2021)
11.9.5 Johnson & Johnson Recent Development
11.10 Protein Sciences
11.10.1 Protein Sciences Company Details
11.10.2 Protein Sciences Business Overview
11.10.3 Protein Sciences Infectious Disease Drugs Introduction
11.10.4 Protein Sciences Revenue in Infectious Disease Drugs Business (2016-2021)
11.10.5 Protein Sciences Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Infectious Disease Drugs Introduction
11.11.4 AstraZeneca Revenue in Infectious Disease Drugs Business (2016-2021)
11.11.5 AstraZeneca Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Infectious Disease Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibacterials
Table 3. Key Players of Antiviral drugs
Table 4. Key Players of Antiparasitic drugs
Table 5. Key Players of Antifungal
Table 6. Key Players of Others
Table 7. Global Infectious Disease Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Infectious Disease Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Infectious Disease Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Infectious Disease Drugs Market Share by Regions (2016-2021)
Table 11. Global Infectious Disease Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Infectious Disease Drugs Market Share by Regions (2022-2027)
Table 13. Infectious Disease Drugs Market Trends
Table 14. Infectious Disease Drugs Market Drivers
Table 15. Infectious Disease Drugs Market Challenges
Table 16. Infectious Disease Drugs Market Restraints
Table 17. Global Infectious Disease Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Infectious Disease Drugs Market Share by Players (2016-2021)
Table 19. Global Top Infectious Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Drugs as of 2020)
Table 20. Ranking of Global Top Infectious Disease Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Infectious Disease Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Infectious Disease Drugs Product Solution and Service
Table 24. Date of Enter into Infectious Disease Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Infectious Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Infectious Disease Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Infectious Disease Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Infectious Disease Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Infectious Disease Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Infectious Disease Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Infectious Disease Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Infectious Disease Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Infectious Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Infectious Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Infectious Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Infectious Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Infectious Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Infectious Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Infectious Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Infectious Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Infectious Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Infectious Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Infectious Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Infectious Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Infectious Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Infectious Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Infectious Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Infectious Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Infectious Disease Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Infectious Disease Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Infectious Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Infectious Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Infectious Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Infectious Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Infectious Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Infectious Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Infectious Disease Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Infectious Disease Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Infectious Disease Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Infectious Disease Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Infectious Disease Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Infectious Disease Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline Infectious Disease Drugs Product
Table 67. GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million)
Table 68. GlaxoSmithKline Recent Development
Table 69. Gilead Sciences Company Details
Table 70. Gilead Sciences Business Overview
Table 71. Gilead Sciences Infectious Disease Drugs Product
Table 72. Gilead Sciences Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million)
Table 73. Gilead Sciences Recent Development
Table 74. Merck & Co. Company Details
Table 75. Merck & Co. Business Overview
Table 76. Merck & Co. Infectious Disease Drugs Product
Table 77. Merck & Co. Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million)
Table 78. Merck & Co. Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Infectious Disease Drugs Product
Table 82. Pfizer Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. Sanofi Company Details
Table 85. Sanofi Business Overview
Table 86. Sanofi Infectious Disease Drugs Product
Table 87. Sanofi Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million)
Table 88. Sanofi Recent Development
Table 89. AbbVie Company Details
Table 90. AbbVie Business Overview
Table 91. AbbVie Infectious Disease Drugs Product
Table 92. AbbVie Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million)
Table 93. AbbVie Recent Development
Table 94. Shire Company Details
Table 95. Shire Business Overview
Table 96. Shire Infectious Disease Drugs Product
Table 97. Shire Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million)
Table 98. Shire Recent Development
Table 99. Grifols Company Details
Table 100. Grifols Business Overview
Table 101. Grifols Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million)
Table 102. Grifols Recent Development
Table 103. Johnson & Johnson Company Details
Table 104. Johnson & Johnson Business Overview
Table 105. Johnson & Johnson Infectious Disease Drugs Product
Table 106. Johnson & Johnson Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million)
Table 107. Johnson & Johnson Recent Development
Table 108. Protein Sciences Company Details
Table 109. Protein Sciences Business Overview
Table 110. Protein Sciences Infectious Disease Drugs Product
Table 111. Protein Sciences Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million)
Table 112. Protein Sciences Recent Development
Table 113. AstraZeneca Company Details
Table 114. AstraZeneca Business Overview
Table 115. AstraZeneca Infectious Disease Drugs Product
Table 116. AstraZeneca Revenue in Infectious Disease Drugs Business (2016-2021) & (US$ Million)
Table 117. AstraZeneca Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Drugs Market Share by Type: 2020 VS 2027
Figure 2. Antibacterials Features
Figure 3. Antiviral drugs Features
Figure 4. Antiparasitic drugs Features
Figure 5. Antifungal Features
Figure 6. Others Features
Figure 7. Global Infectious Disease Drugs Market Share by Application: 2020 VS 2027
Figure 8. HIV Case Studies
Figure 9. Malaria Case Studies
Figure 10. Hepatitis Case Studies
Figure 11. Influenza Case Studies
Figure 12. HPV Case Studies
Figure 13. Tuberculosis Case Studies
Figure 14. Others Case Studies
Figure 15. Infectious Disease Drugs Report Years Considered
Figure 16. Global Infectious Disease Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Infectious Disease Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Infectious Disease Drugs Market Share by Regions: 2020 VS 2027
Figure 19. Global Infectious Disease Drugs Market Share by Regions (2022-2027)
Figure 20. Global Infectious Disease Drugs Market Share by Players in 2020
Figure 21. Global Top Infectious Disease Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Drugs as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Infectious Disease Drugs Revenue in 2020
Figure 23. Global Infectious Disease Drugs Revenue Market Share by Type (2016-2021)
Figure 24. Global Infectious Disease Drugs Revenue Market Share by Type (2022-2027)
Figure 25. North America Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Infectious Disease Drugs Market Share by Type (2016-2027)
Figure 27. North America Infectious Disease Drugs Market Share by Application (2016-2027)
Figure 28. North America Infectious Disease Drugs Market Share by Country (2016-2027)
Figure 29. United States Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Infectious Disease Drugs Market Share by Type (2016-2027)
Figure 33. Europe Infectious Disease Drugs Market Share by Application (2016-2027)
Figure 34. Europe Infectious Disease Drugs Market Share by Country (2016-2027)
Figure 35. Germany Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Infectious Disease Drugs Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Infectious Disease Drugs Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Infectious Disease Drugs Market Share by Region (2016-2027)
Figure 45. China Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Infectious Disease Drugs Market Share by Type (2016-2027)
Figure 53. Latin America Infectious Disease Drugs Market Share by Application (2016-2027)
Figure 54. Latin America Infectious Disease Drugs Market Share by Country (2016-2027)
Figure 55. Mexico Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Infectious Disease Drugs Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Infectious Disease Drugs Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Infectious Disease Drugs Market Share by Country (2016-2027)
Figure 61. Turkey Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Infectious Disease Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. GlaxoSmithKline Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021)
Figure 65. Gilead Sciences Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021)
Figure 66. Merck & Co. Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021)
Figure 68. Sanofi Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021)
Figure 69. AbbVie Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021)
Figure 70. Shire Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021)
Figure 71. Grifols Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021)
Figure 72. Johnson & Johnson Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021)
Figure 73. Protein Sciences Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021)
Figure 74. AstraZeneca Revenue Growth Rate in Infectious Disease Drugs Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

---